echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > 13 province action! The time for the expansion of belt capacity in 8 provinces has been set: Henan, Zhejiang

    13 province action! The time for the expansion of belt capacity in 8 provinces has been set: Henan, Zhejiang

    • Last Update: 2019-10-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Finishing: Corn 13 provinces to expand the procurement volume, 8 provinces time set Recently, the general office of Shandong provincial government printed and distributed the implementation plan for implementing the pilot expansion of centralized procurement and use of drugs organized by the state in Shandong Province, which was implemented in Shandong Province Shandong said it had implemented the 25 generic drugs in the pilot project of centralized purchase and use of drugs organized by the state In the future, according to the unified deployment of national centralized procurement and use reform, the scope of centralized procurement varieties will be gradually expanded The message is very clear If the negotiation of the next batch of products purchased with volume is successful, it is likely to be carried out quickly on the existing basis This shows the trend of purchasing with volume The first batch is pilot in 11 cities, following the expansion, and then continue to select and negotiate the next batch of varieties Shandong requires all public medical institutions in the province to participate in the pilot expansion, and encourages private medical institutions and retail pharmacies designated by medical insurance to actively participate Shandong made it clear that medical institutions, as the first person responsible for the settlement of drug payments, should ensure that the payment of drug payments is completed from the date of delivery and acceptance of selected drugs to the end of the second month On the basis of the total budget, the medical insurance fund shall be prepaid to the medical institutions at least 50% of the purchase amount agreed in the selected drugs contract, and shall be appropriated in place before the implementation of the centralized purchase results Medical insurance agencies at all levels shall timely allocate medical insurance funds to medical institutions in accordance with regulations, and medical institutions shall not default on enterprise drug payments, and shall not extend the time of payment collection in disguised form by means of acceptance Strictly check the behavior of failing to settle the drug payment on time According to the documents, before the end of November 2019, relevant departments in Shandong Province should formulate and issue supporting documents such as medical insurance payment policy, clinical allocation and use of selected drugs, drug supervision, etc., to ensure the smooth development of pilot expansion Yunnan: purchase agreement period is 1-3 years Since September 30, nine departments including the State Medical Security Bureau issued the opinions on the implementation of the pilot project of centralized purchase and use of drugs organized by the state to expand the regional scope, China has made a positive breakthrough Recently, many provinces have announced their own plans According to the information gathered from Nanyang Pharmaceutical Co., Ltd., the implementation plan (Draft for comments) for Yunnan Province to implement the pilot project of centralized procurement and use of drugs organized by the state to expand the regional scope shows that the procurement agreement period set in Yunnan is 1-3 years, depending on the number of selected enterprises However, Yunnan did not announce the implementation time Zhejiang: launched on January 1, 2020 In the same period, the minutes of the Symposium on centralized drug procurement in the alliance region (Zhejiang) flowed out, which was launched in Zhejiang or on January 1, 2020 to implement national policies and prepay 30% of the payment Jiangsu, Shanxi, Jiangxi and Inner Mongolia started On October 25, the Jiangsu health and Health Commission issued the notice on doing well in the clinical allocation and use of selected drugs in the centralized purchase of drugs organized by the state (swbgyz [2019] No 31), informing the health and health committees of all districts and cities and the provincial administration of relevant hospitals that priority should be given to the preparation and rational use of selected drugs for the selected varieties, so as to increase the use proportion of selected drugs This indicates that the expansion of procurement with volume will be implemented in Jiangsu Province On October 21, 2019, the people's Government of Shanxi Province issued the notice of the general office of the people's Government of Shanxi Province on printing and distributing the implementation plan of promoting the centralized and volume purchase and use of drug consumables in Shanxi Province, which requires that the products selected in the volume purchase organized by the State shall be implemented in accordance with the relevant procurement and use policies of the state According to the information released by Jiangxi Medical Insurance Bureau, on October 23, Yi Lianhong, governor of Jiangxi Province, presided over the 33rd executive meeting of the provincial government, deliberated and approved in principle the implementation plan for implementing the pilot work of centralized procurement and use of drugs organized by the state in Jiangxi Province and the implementation plan for carrying out the work of procurement and use of drugs in volume in Jiangxi Province It was decided at the meeting that all public medical institutions in the province should be included in the pilot areas of centralized drug purchase and use organized by the state to expand the scope of the region, and medical insurance designated social medical institutions and medical insurance designated retail pharmacies should be encouraged to participate voluntarily On October 16, 2019, the medical insurance bureau of Inner Mongolia Autonomous Region issued the supporting measures for medical insurance of Inner Mongolia Medical Security Bureau, Department of finance, health and Health Commission on the pilot expansion of national drug centralized procurement and use (Draft for comments), and solicited opinions on the overall implementation of the 4 + 7 expansion Henan: fully launched on December 31, 2019 Recently, the health insurance bureau of Henan Province issued the implementation plan for the implementation of the pilot expansion of centralized drug procurement and use in Henan Province (Draft for comments) The document shows that December 2019 to December 2020 is the implementation stage, and the pilot expansion will be fully launched on December 31, 2019 Guizhou: launched in January 2020 Recently, according to the work time arrangement and responsibility division of Guizhou Province for national drug centralized procurement and use pilot to expand regional scope, Guizhou Province will start the 4 + 7 expansion in January 2020 Jilin: implemented in December 2019 On October 18, Jilin Medical Insurance Bureau released the implementation opinions of Jilin Province on doing well in centralized drug purchase and use pilot and expanding regional scope (draft on behalf of Jilin Province) The implementation stage of the expansion of volume purchase in Jilin Province is from December 2019 to December 2020, that is to say, it will be implemented in December Guangdong: implemented in January 2020 On October 13, Guangdong Medical Insurance Bureau issued the implementation plan for promoting the implementation of the pilot expansion of centralized drug procurement and use organized by the state (Draft for comments) The implementation stage of the expansion of volume purchase is from January to December 2020, i.e from January next year Hubei and Anhui: launched in December 2019 On October 10, Hubei Medical Insurance Bureau said that it would implement the procurement, supply, use, prepayment of medical insurance fund and timely payment of payment for selected drugs in accordance with the implementation plan and relevant supporting policies from December 2019 to December 2020.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.